to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to
Cross-sectional associations of C-reactive protein with vascular risk factors and vascular complications in the DCCT/EDIC cohort.
Critical evaluation of adult treatment panel III criteria in identifying insulin resistance with dyslipidemia.
Adiponectin reduces lipid accumulation in macrophage foam cells.
Effects of macrophage-specific adiponectin expression on lipid metabolism in vivo.
Plasma total homocysteine and carotid intima-media thickness in type 1 diabetes: a prospective study.
Adiponectin and the metabolic syndrome: mechanisms mediating risk for metabolic and cardiovascular disease.
Effects of short-term very low-calorie diet on intramyocellular lipid and insulin sensitivity in nondiabetic and type 2 diabetic subjects.
Initial combination therapy with metformin and colesevelam for achievement of glycemic and lipid goals in early type 2 diabetes.
Lipoprotein lipase S447X variant associated with VLDL, LDL and HDL diameter clustering in the MetS.
Relationship between Insulin Sensitivity and Muscle Lipids may Differ with Muscle Group and Ethnicity.
A clustering analysis of lipoprotein diameters in the metabolic syndrome.
VPO1 mediates ApoE oxidation and impairs the clearance of plasma lipids.
Cardiometabolic disease risk in metabolically healthy and unhealthy obesity: Stability of metabolic health status in adults.
Deletion of the Toll-Like Receptor 5 Gene Per Se Does Not Determine the Gut Microbiome Profile That Induces Metabolic Syndrome: Environment Trumps Genotype.
Trends in Cardiovascular Health Metrics in Obese Adults: National Health and Nutrition Examination Survey (NHANES), 1988-2014.
Dual energy X-ray absorptiometry assessment of fat mass distribution and its association with the insulin resistance syndrome.
Semaglutide improves cardiometabolic risk factors in adults with overweight or obesity: STEP 1 and 4 exploratory analyses.